Yoav Elishoov

Yoav brings vast experience in commercial, market access, regulatory affairs, and marketing roles in global Pharmaceutical companies. Yoav served as the CEO of Trima Ltd, an Israeli pharmaceutical company involves in generic R&D. Under his supervision the company turned its sales rate to sustainable growth annually. He Positioned the company to become a local generic R&D powerhouse, introducing 4-5 new products annually. Prior to this, Yoav has established the Oncology Business Unit of Novartis Israel as a new entity and managed it for more than a decade. During those years he was personally involved in launching Novartis Oncology mega brands, and made Novartis’s Israel business unit the sub-region top market leader .During his time at Novartis Oncology Yoav also led CIS markets, and brought regional management experience of 5 years. Before that Yoav served as the regulatory affairs Director of Novartis Israel. All these positions involved commercial, operational and regulatory communications across global/multinational entities.